NASDAQ-GS · traded in Congress
Ultragenyx Pharmaceutical RARE
$15.49 +0.06 (+0.39%) Nov 9, 2026 4:01 AM ET
Chart
Analyst ratings
- 11 buy
- 11 hold
- 0 sell
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $173M | - | $-118M | -68.2% | |
| $214M | - | $-92M | -43.0% | |
| $136M | - | $-185M | -136.0% | |
| $207M | - | $-129M | -62.3% |
Congress trades in RARE
Members of Congress disclosed 3 transactions in RARE in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/29/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 10/12/2026 filing |
| 03/03/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
| 02/18/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 3/9/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Our coverage
- Jobless claims fall to 189,000, matching the lowest since 1969, as layoffs stay rare Economy · November 5, 2026
- Jobless claims 197,000; people on benefits drop to 1.701 million as September job cuts hit 43,281 Economy · October 1, 2026
- Bessent says the U.S. is open to extending the China trade truce that ends Nov. 10, or a bigger deal Economy · September 23, 2026
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.

